Naumovski L - Search Results

1

The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.

Evens AM, Spies WG, Helenowski IB, Patton D, Spies S, Jovanovic BD, Miyata S, Hamilton E, Variakojis D, Chen J, Naumovski L, Rosen ST, Winter JN, Miller RA, Gordon LI. Evens AM, et al. Among authors: naumovski l. Clin Cancer Res. 2009 Oct 15;15(20):6462-71. doi: 10.1158/1078-0432.CCR-09-0905. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825958 Free PMC article. Clinical Trial.

2

Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.

Lin TS, Naumovski L, Lecane PS, Lucas MS, Moran ME, Cheney C, Lucas DM, Phan SC, Miller RA, Byrd JC. Lin TS, et al. Among authors: naumovski l. Leuk Lymphoma. 2009 Dec;50(12):1977-82. doi: 10.3109/10428190903288464. Leuk Lymphoma. 2009. PMID: 19860624 Clinical Trial.

3

Intracellular redistribution of interferon-inducible proteins Nmi and IFP 35 in apoptotic cells.

Chen J, Naumovski L. Chen J, et al. Among authors: naumovski l. J Interferon Cytokine Res. 2002 Feb;22(2):237-43. doi: 10.1089/107999002753536211. J Interferon Cytokine Res. 2002. PMID: 11911807

4

Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines.

Lecane PS, Karaman MW, Sirisawad M, Naumovski L, Miller RA, Hacia JG, Magda D. Lecane PS, et al. Among authors: naumovski l. Cancer Res. 2005 Dec 15;65(24):11676-88. doi: 10.1158/0008-5472.CAN-05-2754. Cancer Res. 2005. PMID: 16357179

5

ARMER, apoptotic regulator in the membrane of the endoplasmic reticulum, a novel inhibitor of apoptosis.

Lui HM, Chen J, Wang L, Naumovski L. Lui HM, et al. Among authors: naumovski l. Mol Cancer Res. 2003 May;1(7):508-18. Mol Cancer Res. 2003. PMID: 12754298

6

Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation.

Ramos J, Sirisawad M, Miller R, Naumovski L. Ramos J, et al. Among authors: naumovski l. Mol Cancer Ther. 2006 May;5(5):1176-82. doi: 10.1158/1535-7163.MCT-05-0280. Mol Cancer Ther. 2006. PMID: 16731749

7

Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis.

Chen J, Ramos J, Sirisawad M, Miller R, Naumovski L. Chen J, et al. Among authors: naumovski l. Apoptosis. 2005 Oct;10(5):1131-42. doi: 10.1007/s10495-005-0887-2. Apoptosis. 2005. PMID: 16151646

8

Motexafin gadolinium-induced cell death correlates with heme oxygenase-1 expression and inhibition of P450 reductase-dependent activities.

Evans JP, Xu F, Sirisawad M, Miller R, Naumovski L, de Montellano PR. Evans JP, et al. Among authors: naumovski l. Mol Pharmacol. 2007 Jan;71(1):193-200. doi: 10.1124/mol.106.028407. Epub 2006 Oct 3. Mol Pharmacol. 2007. PMID: 17018578

9

Tumor localization and antitumor efficacy of novel sapphyrin compounds.

Naumovski L, Sirisawad M, Lecane P, Chen J, Ramos J, Wang Z, Cortez C, Magda D, Thiemann P, Boswell G, Miles D, Cho DG, Sessler JL, Miller R. Naumovski L, et al. Mol Cancer Ther. 2006 Nov;5(11):2798-805. doi: 10.1158/1535-7163.MCT-06-0246. Mol Cancer Ther. 2006. PMID: 17121926

10

ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.

Wang J, Anderson MG, Oleksijew A, Vaidya KS, Boghaert ER, Tucker L, Zhang Q, Han EK, Palma JP, Naumovski L, Reilly EB. Wang J, et al. Among authors: naumovski l. Clin Cancer Res. 2017 Feb 15;23(4):992-1000. doi: 10.1158/1078-0432.CCR-16-1568. Epub 2016 Aug 29. Clin Cancer Res. 2017. PMID: 27573171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters